The G7 Summit 2021: time for our world leaders to step up to the challenge of antimicrobial resistance

References

1. Joshi LT. The next pandemic is already here – why our world leaders should take notice of antimicrobial resistance; 2021 https://www.newstatesman.com/spotlight/healthcare/2021/06/next-pandemic-already-here-why-our-world-leaders-should-take-notice29 July 2021
2. G7 Summit; 2021 https://www.g7uk.org/14 May 2021
3. Laub Z, McBride J. The group of seven (G7). Council on Foreign Relations; 2017; 30
4. Lima de Miranda K, Snower D. The Societal Responses to Covid-19: Evidence from the G7 Countries 2021
   [Google Scholar]
5. Walsh TR. A one-health approach to antimicrobial resistance. Nat Microbiol 2018; 3:854–855 [View Article] [PubMed]
   [Google Scholar]
6. O’Neill J. Review on antimicrobial resistance: tackling drug-resistant infections globally: final report and recommendations; 2016 https://amr-review.org/15 May 2021
7. WHO Coronavirus (COVID-19) Dashboard; 2021 https://covid19.who.int/15 May 2021
8. G7 Carbis Bay Health Declaration; 2021 https://www.g7uk.org/wp-content/uploads/2021/06/G7-Carbis-Bay-Health-Declaration-PDF-389KB-4-Pages.pdf01 August 2021
9. G7 Health Ministers Communique; 2021 https://www.g7uk.org/g7-health-ministers-meeting-communique-oxford-4-june-2021/01 August 2021
10. WHO Report Global Shortage of Antibiotics; 2021 https://www.who.int/news/item/15-04-2021-global-shortage-of-innovative-antibiotics-fuels-emergence-and-spread-of-drug-resistance17 May 2021
11. Mahase E. UK launches subscription style model for antibiotics to encourage new development. BMJ 2020m2468 [View Article]
    [Google Scholar]
12. Murphy J, Vallières F, Bentall RP, Shevlin M, McBride O et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun 2021; 12:1–15 [View Article]
    [Google Scholar]
13. Vanguard Report: Antimicrobial resistance and the future of diagnostic testing; 2021 https://bsac.org.uk/vanguard-report-amr-and-the-future-of-diagnostic-testing/17 May 2021
14. UK Government Tackling antimicrobial resistance 2019–2024; 2019 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/784894 /UK_AMR_5_year_national_action_plan.pdf01 August 2021
15. NIHR Antimicrobial Stewardship: Systems and Processes for Effective Antimicrobial Medicine Use London, UK: National Institute for Health and Care Excellence; 2015
    [Google Scholar]
16. Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R et al. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis 2000; 30:454–460 [View Article] [PubMed]
    [Google Scholar]
17. Davenport M, Mach KE, Shortliffe LMD, Banaei N, Wang TH et al. New and developing diagnostic technologies for urinary tract infections. Nat Rev Urol 2017; 14:296–310296 [View Article] [PubMed]
    [Google Scholar]
18. Public Health England English surveillance programme for antimicrobial utilisation and resistance (ESPAUR); 2017 https://webarchive.nationalarchives.gov.uk/ukgwa/20181130125613/https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report01 August 2021
19. Smieszek T, Pouwels KB, Dolk FCK, Smith DRM, Hopkins S et al. Potential for reducing inappropriate antibiotic prescribing in English primary care. J Antimicrob Chemother 2018; 73:ii36–ii43 [View Article] [PubMed]
    [Google Scholar]
20. Franz AR, Steinbach G, Kron M, Pohlandt F. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics 1999; 104:447–453 [View Article] [PubMed]
    [Google Scholar]
21. Gwyn L, Harris S, Clarke C. Evaluating a point-of-care C-reactive protein test to support antibiotic prescribing decisions in a general practice. Suicide 2019; 14:20
    [Google Scholar]
22. Nora D, Salluh J, Martin-Loeches I, Póvoa P. Biomarker-guided antibiotic therapy—strengths and limitations. Ann Transl Med 2017; 5:208 [View Article]
    [Google Scholar]
23. Wuijts S, van den Berg HHJL, Miller J, Abebe L, Sobsey M et al. Towards a research agenda for water, sanitation and antimicrobial resistance. J Water Health 2017; 15:175–184 [View Article] [PubMed]
    [Google Scholar]
24. Maillard JY, Bloomfield SF, Courvalin P, Essack SY, Gandra S et al. Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paper. Am J Infect Control 2020; 48:1090–1099 [View Article] [PubMed]
    [Google Scholar]
25. Jones IA, Joshi LT. Biocide use in the antimicrobial era: a review. Molecules 2021; 26:2276. [View Article] [PubMed]
    [Google Scholar]
26. Leridon H. World population outlook: Explosion or implosion?. Population Societies 2020; 1:1–4
    [Google Scholar]
27. Amarasiri M, Sano D, Suzuki S. Understanding human health risks caused by antibiotic resistant bacteria (ARB) and antibiotic resistance genes (ARG) in water environments: Current knowledge and questions to be answered. Crit Rev Environ Sci Technol 2019; 50:2016–2059 [View Article]
    [Google Scholar]
28. Joshi LT. Global challenges intertwined: how climate change is linked to antimicrobial resistance; 2019 https://www.plymouth.ac.uk/news/pr-opinion/global-challenges-intertwined-how-climate-change-is-linked-to-antimicrobial-resistance28 July 2021
29. Scholtus E. Foreign Aid Cuts: Now is not the time to step back; 2021 https://microbiologysociety.org/blog/foreign-aid-cuts-now-is-not-the-time-to-step-back.html10 August 2021